Here are the 8-K filings from Copley Acquisition Corp (COPL) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow COPL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COPL filings page.
Copley Acquisition Corp (COPL) adjourned its extraordinary general meeting from October 29, 2026, to November 2, 2026, at 11:00 a.m. Eastern time. Shareholders will vote on amendments that, if approved, would permit the board to extend the deadline for an initial business combination by up to 12 one-month periods, from November 2, 2026, through November 2, 2027. The company said the adjournment gives shareholders who previously voted against both proposals time to reverse those votes; only holders of ordinary shares as of October 19, 2026, are entitled to vote.
Copley Acquisition Sponsors, LLC or its designees revised their proposed contribution from $150,000 to $200,000 for each one-month extension used, contingent on both amendments being approved and implemented. Each contribution is to be deposited two days before the extension. Copley also waived withdrawals of up to $100,000 of trust interest for dissolution expenses and waived interest withdrawals for future tax expenses. Trust funds, including contributions, are held in an interest-bearing demand deposit account until the earlier of a business combination or liquidation; waived interest remains in trust until a business combination or specified redemptions.
Copley Acquisition Corp (COPL) and Ignite Proteomics, LLC mutually terminated their business combination agreement, effective immediately on October 9, 2026. The agreement had been entered into on June 10, 2026. Following termination, the parties have no further rights, remedies, liabilities or obligations under that agreement except for specified provisions that survive.
Related ancillary documents, including the Seller Support Agreements, Insider Letter Amendment and Lock-Up Agreements, terminated at the same time. Each party will bear its own expenses, and the termination agreement provides mutual releases for claims relating to the business combination agreement and contemplated transactions, except claims under the termination agreement.
Copley intends to continue pursuing a business combination and currently has until November 2, 2026, to complete one, subject to extension under its organizational documents. Copley identifies its ability to find a suitable target and complete a transaction within the required period, as well as the possibility of redeeming public shares and liquidating its trust account, among the risks.
Copley Acquisition Corp (COPL) issued Copley Acquisition Sponsors LLC an amended and restated convertible promissory note on October 6, 2026, increasing the maximum aggregate principal amount available from $450,000 to $900,000. The note bears no interest, and its proceeds are for COPL’s working capital. It replaces the prior note.
Outstanding principal is due on the earlier of the effective date of a business combination or COPL’s liquidation. The Sponsor may elect, on or before that date, to convert any amount outstanding into units at $7.00 per unit. Each unit consists of one ordinary share and one-half of one redeemable warrant. If COPL does not consummate a business combination, repayment is limited to amounts, if any, remaining outside the trust account.
Copley Acquisition Corp entered into a Business Combination Agreement with Ignite Proteomics to take Ignite public through a new holding company, Ignite Proteomics Holdings, Inc. Pubco is expected to list on the NYSE and own both Copley and Ignite after closing.
Ignite’s owners will receive Pubco common stock valued at $150,000,000, calculated at $10.00 per share, while Pubco will also pay $4,000,000 in cash to a Copley sponsor affiliate at closing. Copley aims to raise up to $20,000,000 and Ignite up to $10,000,000 of additional financing during the interim period.
Closing requires shareholder approvals, an effective Form S-4, NYSE listing for Pubco shares and warrants, and minimum cash conditions of at least $15,000,000 from Copley-related sources and $7,500,000 from Ignite financing. If not completed by September 30, 2026, or if key conditions fail, either side may terminate under specified circumstances.